Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PTAFR | P25105 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9532304 | 1.00 | GMNN (0.40) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9528828 | 0.84 | ATM (0.41) | — | |
| SCHEMBL9528831 | 0.84 | ATM (0.41) | — | |
| SCHEMBL9798998 | 0.82 | GMNN (0.41) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9798991 | 0.82 | GMNN (0.41) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9532112 | 0.79 | ATM (0.42) | — | |
| SCHEMBL9530013 | 0.79 | SMN1; SMN2 (0.50) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9530021 | 0.79 | SMN1; SMN2 (0.50) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9531777 | 0.79 | PLA2G2A (0.39) | — | |
| SCHEMBL9529278 | 0.78 | HPGD (0.42) | TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0238202-B1 | GLYCEROL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | Sankyo Company Limited (JP) | 1993-04-28 | — | — | EP | disclosed |
| US-5068340-A | Antagonist of platelet activating factor for treatment of asthma, inflammation or shock | SANKYO COMPANY, LIMITED (JP) | 1991-11-26 | — | — | US | disclosed |
| EP-0238202-A2 | Glycerol derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1987-09-23 | — | — | EP | disclosed |